How Ketamine Spawned a $1.7 Billion J&J Blockbuster Drug
Why it matters
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Article tone
Neutral
How the article is written, as reported by the source.
Expected market reaction
Evidence trail
Evidence
Source
Bloomberg
Claim
How Ketamine Spawned a $1.7 Billion J&J Blockbuster Drug
AI inference
Neutral · 94%
Generated
2026-04-30 20:00
AI provenance
Technical identifiers
- Provider tag
- huggingface-ProsusAI/finbert
- Analysis version
- huggingface-ProsusAI/finbert
- Article id
- 78176
Original source
Spravato, the ketamine-derived nasal spray from Johnson & Johnson, was once seen as a long shot. It was difficult to deliver, heavily regulated and slow to catch on. Find out how it became a billion-dollar drug and part of a new model for treating depression. (Source: Bloomberg)
Read the full article on Bloomberg
Original article published by Bloomberg on April 30, 2026. Analysis and insights provided by AnalystMarkets AI.